Data synthesis and analysis The main outcomes analyzed were the pooled mean differences in BMI reduction from baseline to posttreatment, and risk ratio (RR) for headache, visual disturbances, refractory IIH and papilledema between the GLP agonist and control groups
One important finding from clinical trials is that gastrointestinal side effects like nausea, vomiting, diarrhea are highly related to the medication dose and the rate the dose is increased
7 It has been shown that GLP-1 receptors in the choroid plexus alter Na+/K+-ATPase activity, which directly influences CSF production and may reduce ICP without exclusively depending on weight reduction
Additional Information OKDERMO, Skin, Health & Beauty Blog OKDERMO's blog is your go-to source for skincare expertise
[8] Until it does, an honest description goes like this: microdosing is what medicine calls a clinical extrapolation, which is essentially an educated bridge between two proven points
Results The study found that approximately 136.8 million US adults, which constituted over half of the adult population of the country, were eligible for semaglutide treatment